Early invasive treatment for acute coronary syndrome in patients with chronic kidney disease: Do we know what we're doing?

Future Cardiology

Volumn 11, Issue 1, 2015, Pages 5-8

  Shaw, Catriona ^a,b   Sharpe, Claire C ^b  

^a SOUTHMEAD HOSPITAL   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE CORONARY SYNDROME; ANGIOCARDIOGRAPHY; CHRONIC KIDNEY DISEASE; DISEASE REGISTRY; HEART MUSCLE REVASCULARIZATION; HUMAN; INVASIVE PROCEDURE; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; SURVIVAL; ACUTE KIDNEY INJURY; CHRONIC KIDNEY FAILURE; COMPLICATION; MYOCARDIAL INFARCTION; TIME TO TREATMENT;

ACUTE CORONARY SYNDROME; ACUTE KIDNEY INJURY; CORONARY ANGIOGRAPHY; HUMANS; MYOCARDIAL INFARCTION; MYOCARDIAL REVASCULARIZATION; RENAL INSUFFICIENCY, CHRONIC; TIME-TO-TREATMENT;

EID: 84921634415     PISSN: 14796678     EISSN: 17448298     Source Type: Journal    
DOI: 10.2217/fca.14.71     Document Type: Review

References (24)

1. Eckardt K-U, Coresh J, Devuyst O et al. Evolving importance of kidney disease: from subspecialty to global health burden. Lancet 382(9887), 158-169 (2013).
2. Van Der Velde M, Matsushita K, Coresh J et al. Lower estimated glomerular filtration rate and higher albuminuria are associated with all-cause and cardiovascular mortality. A collaborative meta-analysis of high-risk population cohorts. Kidney Int. 79(12), 1341-1352 (2011).
3. Gansevoort RT, Matsushita K, Van Der Velde M et al. Lower estimated GFR and higher albuminuria are associated with adverse kidney outcomes. A collaborative meta-analysis of general and high-risk population cohorts. Kidney Int. 80(1), 93-104 (2011).
4. Gansevoort RT, Correa-Rotter R, Hemmelgarn BR et al. Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention. Lancet 382(9889), 339-352.
5. Herzog CA, Asinger RW, Berger AK et al. Cardiovascular disease in chronic kidney disease. A clinical update from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int. 80(6), 572-586 (2011).
6. Shaw C, Nitsch D, Steenkamp R et al. Inpatient coronary angiography and revascularisation following non-ST-elevation acute coronary syndrome in patients with renal impairment: a cohort study using the Myocardial Ischaemia National Audit Project. PLoS ONE 9(6), e99925 (2014).
7. Fox CS, Muntner P, Chen AY et al. Use of evidence-based therapies in short-term outcomes of ST-segment elevation myocardial infarction and non-ST-segment elevation myocardial infarction in patients with chronic kidney disease: a report from the National Cardiovascular Data Acute Coronary Treatment and Intervention Outcomes Network Registry. Circulation 121(3), 357-365 (2010).
8. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu C-Y. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N. Engl. J. Med. 351(13), 1296-1305 (2004).
9. Kerr M, Bray B, Medcalf J, O'Donoghue DJ, Matthews B. Estimating the financial cost of chronic kidney disease to the NHS in England. Nephrol. Dial Transplant 27(Suppl. 3), iii73-iii80 (2012).
10. Hamm CW, Bassand J-P, Agewall S et al. ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: the Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC). Eur. Heart J. 32(23), 2999-3054 (2011).
11. Jneid H, Anderson JL, Wright RS et al. 2012 ACCF/AHA focused update of the guideline for the management of patients with unstable angina/non-ST-elevation myocardial infarction (updating the 2007 guideline and replacing the 2011 focused update): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation 126(7), 875-910 (2012).
12. Charytan D, Mauri L, Agarwal A, Servoss S, Scirica B, Kuntz RE. The use of invasive cardiac procedures after acute myocardial infarction in long-term dialysis patients. Am. Heart J. 152(3), 558-564 (2006).
13. Wong JA, Goodman SG, Yan RT et al. Temporal management patterns and outcomes of non-ST elevation acute coronary syndromes in patients with kidney dysfunction. Eur. Heart J. 30(5), 549-557 (2009).
14. Szummer K, Lundman P, Jacobson SH et al. Influence of renal function on the effects of early revascularization in non-ST-elevation myocardial infarction: data from the Swedish Web-system for Enhancement and Development of Evidence-based Care in Heart Disease Evaluated According to Recommended Therapies (SWEDEHEART). Circulation 120(10), 851-858 (2009).
15. Kanderian AS, Francis GS. Cardiac troponins and chronic kidney disease. Kidney Int. 69(7), 1112-1114 (2006).
16. James MT, Tonelli M, Ghali WA et al. Renal outcomes associated with invasive versus conservative management of acute coronary syndrome: propensity matched cohort study. BMJ 347, f4151 (2013).
17. Coca SG, Krumholz HM, Garg AX, Parikh CR. UNderrepresentation of renal disease in randomized controlled trials of cardiovascular disease. JAMA 296(11), 1377-1384 (2006).
18. Charytan DM, Wallentin L, Lagerqvist B et al. Early angiography in patients with chronic kidney disease: a collaborative systematic review. Clin. J. Am. Soc. Nephrol. 4(6), 1032-1043 (2009).
19. Young Altahan R, Goldenberg I, Kimron L, Barsheshet A, Guetta V. Timing of coronary angiography and outcome in patients with non-ST elevation acute coronary syndromes and kidney disease: real-world data from the acute coronary syndromes Israeli survey. Cardiology 119(4), 224-234 (2011).
20. Bhatt DL, Roe MT, Peterson ED et al. Utilization of early invasive management strategies for high-risk patients with non-st-segment elevation acute coronary syndromes: results from the crusade quality improvement initiative. JAMA 292(17), 2096-2104 (2004).
21. Goldenberg I, Subirana I, Boyko V et al. Relation between renal function and outcomes in patients with non-ST-segment elevation acute coronary syndrome: real-world data from the european public health outcome research and indicators collection project. Arch. Intern. Med. 170(10), 888-895 (2010).
22. Pocock SJ, Elbourne DR. Randomized trials or observational tribulations? N. Engl. J. Med. 342(25), 1907-1909 (2000).
23. Fröbert O, Lagerqvist B, Olivecrona GK et al. Thrombus aspiration during ST-segment elevation myocardial Infarction. N. Engl. J. Med. 369(17), 1587-1597 (2013).
24. Lauer MS, D'Agostino RB Sr. The randomized registry trial-the next disruptive technology in clinical research? N. Engl. J. Med. 369(17), 1579-1581 (2013).